Appointment of Catherine Moukheibir to the Executive board of Innate Pharma

Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces today the reinforcement of its management with the appointment of Catherine Moukheibir to its Executive board, as Senior Advisor Finance.

PR in English 152.51 KB
CP en français 142.55 KB